|1.||Kruzliak, Peter: 3 articles (05/2014 - 04/2013)|
|2.||Bonavida, Benjamin: 3 articles (11/2008 - 06/2004)|
|3.||Sprigg, Nikola: 2 articles (11/2015 - 11/2006)|
|4.||Huerta, Sergio: 2 articles (08/2015 - 11/2008)|
|5.||Dowswell, Therese: 2 articles (01/2015 - 01/2014)|
|6.||Carbonne, Bruno: 2 articles (12/2014 - 08/2007)|
|7.||Sulowska, Zofia: 2 articles (11/2014 - 11/2013)|
|8.||Kielbik, Michal: 2 articles (11/2014 - 11/2013)|
|9.||Brzezinska, Marta: 2 articles (11/2014 - 11/2013)|
|10.||Szulc, Izabela: 2 articles (11/2014 - 11/2013)|
05/01/2004 - "Recently, protective effects of nitric oxide donors in pancreatic ischemia/reperfusion (IRI) injury have been described. "
03/15/1995 - "Nitric oxide donors improve gut function after prolonged hypothermic ischemia."
07/01/2002 - "Nitric oxide donors may be a promising family of therapeutic agents for the prevention of ischemia-induced reperfusion injury in cutaneous and myocutaneous flaps."
03/01/1994 - "Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia."
02/01/2000 - "The reduced endothelial nitric oxide release during ischemia may be involved in the upregulation of intercellular adhesion molecule 1. In this study, we tested if nitric oxide donors suppress polymorphonuclear leukocyte adherence to activated endothelial cells by inhibition of the intercellular adhesion molecule 1 surface expression. "
11/01/2007 - "This review discusses, in particular, the role of the transcriptionally activated NOS-2 (inducible NOS) isoform and summarizes the outcomes of experimental stroke studies with regard to the therapeutic utility of nitric oxide donors and NOS inhibitors."
11/01/2015 - "Nitric oxide donors are candidate treatments for acute stroke, potentially through hemodynamic, reperfusion, and neuroprotectant effects, especially if given early. "
11/01/2006 - "Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke."
09/01/2006 - "Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke."
01/01/2013 - "Nitric oxide donors as neuroprotective agents after an ischemic stroke-related inflammatory reaction."
07/01/1996 - "This study suggests that platelet-specific nitric oxide donors may prove beneficial in the management of severe preeclampsia."
01/01/2007 - "Studies were included if they were randomised trials evaluating nitric oxide donors or precursors for preventing pre-eclampsia and its complications. "
11/01/1998 - "The aim of this study was to determine whether pre-eclampsia and its complications could be prevented by the long-term use of nitric oxide donors in a group of women identified to be at risk on the basis of abnormal uterine artery Doppler measurements. "
01/29/2012 - "Nitric oxide donors are able to compensate the symptoms of preeclampsia. "
01/01/2007 - "There is insufficient evidence to draw reliable conclusions about whether nitric oxide donors and precursors prevent pre-eclampsia or its complications."
04/19/2002 - "Dual effect of local application of nitric oxide donors in a model of incision pain in rats."
01/01/2007 - "The combination of numerous classic drugs with nitric oxide donors has led to the development of new compounds with promising therapeutic activities in a great variety of situations, including cardiovascular and respiratory systems, ocular pressure, inflammation, and pain. "
04/01/2006 - "The COX-inhibiting nitric oxide donors (CINODs) are a new class of agents designed for the treatment of pain and inflammation. "
06/01/2005 - "The observation that nitric oxide donors induce migraine-like pain in migraineours and that nitric oxide plays a pivotal role in the control of several functions in the central nervous system, has prompted the use of such molecules for better understanding the pathophysiology of migraine attacks. "
06/01/1999 - "In conjunction with their opioid tolerance-sparing function, joint delivery of ketamine or nitric oxide donors with opiates may be of significant benefit in cancer pain management."
06/01/1994 - "The findings provide support for the hypothesis that nitric oxide is a mediator of penile erection and that nitric oxide donors may be useful in the treatment of erectile dysfunction."
03/01/2009 - "In four trials, men older than 18 years and with erectile dysfunction, a stable sexual partner, and no recent phosphodiesterase type 5 inhibitor use were randomized to double-blind flexible-dose sildenafil or placebo (1:1 ratio) for 6 or 10 weeks (two trials), fixed-dose 50 mg, 100 mg, and placebo (1:1:1 ratio) for 8 weeks (one trial), and 50 mg and 100 mg (1:1 ratio) for 4 weeks after 4 weeks of single-blind sildenafil 50 mg. Exclusion criteria included recent significant cardiovascular disease, use of nitrates, nitric oxide donors, cytochrome P450 3A4 inhibitors, or other erectile dysfunction treatment, and sildenafil hypersensitivity or previous severe or serious treatment-related adverse event. "
|1.||Nitric Oxide (Nitrogen Monoxide)
|2.||Opioid Analgesics (Opioids)
|6.||Phosphodiesterase 5 Inhibitors
|8.||Nitric Oxide Synthase (NO Synthase)
|1.||Drug Therapy (Chemotherapy)
|5.||Cardiopulmonary Resuscitation (CPR)